Related Experiment Videos

Spontaneous and evoked otoacoustic emissions in pre-term and full-term neonates: is there a clinical application?

T Morlet1, L Collet, R Duclaux

  • 1URA CNRS 1447, Hôpital Edouard Herriot, Lyon, France.

Insights

Early hearing loss detection in neonates is crucial for development. Otoacoustic emission testing is a viable screening method for newborns, even premature infants, from 30 weeks of age.

Area of Science:

  • Neonatal audiology
  • Developmental pediatrics
  • Otoacoustic emissions

Background:

  • Hearing impairment in infants can hinder language and cognitive development.
  • Premature neonates are at higher risk for early-onset hearing loss.
  • Early detection of hearing deficits is critical for timely intervention.

Purpose of the Study:

  • To evaluate the utility of otoacoustic emissions for auditory screening in neonates.
  • To determine the feasibility of using evoked otoacoustic emissions (EOAEs) and spontaneous otoacoustic emissions (SOAEs) in neonatal intensive care units.
  • To establish the earliest conceptional age for reliable EOAE and SOAE recording.

Main Methods:

  • Recording of evoked otoacoustic emissions (EOAEs) and spontaneous otoacoustic emissions (SOAEs).
  • Study conducted on 93 pre-term and full-term neonates.
  • Analysis of SOAE prevalence, ear laterality, and association with EOAE findings.

Main Results:

  • EOAEs and SOAEs can be reliably recorded from 30 weeks of conceptional age.
  • SOAEs were more prevalent in female infants and showed higher peak numbers in the right ear.
  • Higher incidence of SOAEs was observed in ears with positive and robust EOAEs.

Conclusions:

  • Otoacoustic emission testing is a promising tool for neonatal auditory screening.
  • The technique is applicable to both pre-term and full-term neonates from 30 weeks of conceptional age.
  • SOAE characteristics may provide additional information regarding auditory system function in neonates.

Related Concept Videos